CClinicalTrials.gg
CompletedNCT00818402SILKEUpdated May 29, 2015

Non-small Cell Lung Cancer and Quality of Life

An observational study in Non Small Cell Lung Cancer, sponsored by University of Turku. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-05-29.

Sponsored by University of Turku · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
130
Ages
18 Years and older
Sex
All
01

Study summary

The principal objective is to study clinical observations, symptoms and quality of life of non-small-cell lung cancer (NSCLC) patients undergoing specific non-operative treatment for cancer, including chemotherapy and radiotherapy.

02

Conditions studied

  • Non Small Cell Lung Cancer

Keywords

  • Quality of life
  • symptoms
03

In context

Lung Neoplasms

7,243 studies on the registry are indexed under Lung Neoplasms; 1,557 are open to participants now.

This study's enrollment of 130 is below the median of 189 across 1,514 observational studies indexed under Lung Neoplasms.

Browse Lung Neoplasms studies →

Lead sponsor

University of Turku is the lead sponsor of 122 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The patients treated in the clinic of respiratory medicine in Turku, Finland

Inclusion criteria

  • Patients with verified NSCLC
  • after the NSCLC diagnosis has been confirmed prior to first chemotherapy or radiotherapy
  • Finnish speaking patients
  • aged 18 years or more
  • Written informed consent has to be signed

Exclusion criteria

Exclusion Criteria:

  • Patients not consenting to participate in the study
  • patients not able to communicate sufficiently
  • cancer type is other than non-small-cell lung cancer
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
130 participants (actual)
Biospecimen retention
Samples with dna

Groups and cohorts

  • Non-small cell lung cancer patients
06

Study locations

No study locations are listed for this record.

07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 29, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00818402
Lead sponsor
University of Turku
Responsible party
Maria Silvoniemi (MD, University of Turku) — Principal investigator
First posted
Jan 7, 2009
Start date
Aug 2008
Primary completion
Feb 2012
Completion
Feb 2012
Last update
May 29, 2015

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion